Karan Dayanidhi Maran Launches MicroDrama Platform KadhaiShorts with PayPerSeries Model Stellantis Outlines Turnaround Strategy Prediction Markets Face Regulatory Scrutiny Oura Files for IPO CNBC Morning Brief UP Refutes Attorney General Claims Affirms Full Disclosure in Merger Documentation Indian Equity Markets Wobble as Sensex Nifty Fluctuate Hind Zinc SBI Force Motors Among Most Active Geopolitical Risk Irans Suspicion of US Ceasefire Terms Adds Uncertainty for Energy Markets Lenovo Shares Surge Nearly 20 as Record Earnings Highlight AI Revenue Surge Navient Corporation JSM Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Operational Signals CocaCola Consolidated Inc COKE Q1 2026 Earnings Solid EPS Amid Quiet Quarter DCTH Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Strategic Progress Bridger Aerospace Group Holdings Inc BAER Q1 2026 Earnings WiderThanExpected Loss Weighs on Results NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances UiPath PATH Rallies 34 as Automation Stock Tests Resistance Near 1148 Gabelli Healthcare Wellness Trust GRX Holds Steady Near Support Navigating a Tight Trading Range Masonglory Limited MSGY Holds Steady Near Support as Trading Range Tightens First Capital Inc FCAP Gains 095 Resilience Near Support Zone After Modest Rally Energy Recovery Inc ERII Faces Headwinds Stock Slips 114 Amid Key Support Test Samsung Strike Suspended as Union Members Vote on Tentative Deal Amid AI Bonus Demands Essential Utilities Inc WTRG Q1 2026 Earnings EPS Misses Estimates Shares Rise Amid Operational Resilience Duolingo Q1 2026 Earnings EPS Beats Estimates by 164 Shares Edge Lower Crude Oil Prices Decline Amid Speculation Strait of Hormuz May Reopen Michelin Retires Green Star Award Leaving Sustainable Chefs Disappointed SLMBP Q1 2026 Earnings Preferred Stock EPS Surges 356 Above Estimates Reflecting Strong Core Performance Market Update Spotlight on ADTRAN Walmart Snap and Pinterest CVI Q1 2026 Earnings Significant EPS Miss Amidst Challenging Refining Environment Immunovant IMVT Holds Steady Near Support as Biotech Sector Faces Headwinds